The management of metastatic pancreatic cancer: expert discussion and recommendations from the 14th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2012

C. Verslype; E. Van Cutsem; M. Dicato; N. Arber; J.D. Berlin; M.W. Büchler; A. Cervantes; F. Ciardiello; M. Ducreux; J.Y. Douillard; A. Grothey; D. Haller; K. Haustermans; V. Heinemann; M. Hidalgo; R. Labianca; J. Li; J.L. Marshall; B. Nordlinger; E.M. O'Reilly; A. Roth; P. Rougier; D. Ryan; W. Schmiegel; T. Seufferlein; H.J. Schmoll; A. Sobrero; J. Tabernero; M. Tempero; J.L. Van Laethem; M. Ychou; J. Zalcberg

doi:10.1093/annonc/mdt200

Retour

The management of metastatic pancreatic cancer: expert discussion and recommendations from the 14th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2012

Article de revue

Avec comité de lecture

The management of metastatic pancreatic cancer: expert discussion and recommendations from the 14th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2012

C. Verslype, E. Van Cutsem, M. Dicato, N. Arber, J.D. Berlin, M.W. Büchler, A. Cervantes, F. Ciardiello, M. Ducreux, J.Y. Douillard, …

Annals of oncology, Vol.24, pp.iv5-iv10

06/2013

DOI: https://doi.org/10.1093/annonc/mdt200

Résumé

FOLFIRINOX

gemcitabine

nab-paclitaxel

pancreatic cancer

Indicateurs

1 Consultations de la notice

Détails

Titre: The management of metastatic pancreatic cancer: expert discussion and recommendations from the 14th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2012
Créateurs - sans rôle: C. Verslype - Digestive Oncology, University Hospitals Leuven and KU Leuven, Belgium
E. Van Cutsem - Digestive Oncology, University Hospitals Leuven and KU Leuven, Belgium
M. Dicato - Luxembourg Medical Center, Luxembourg, Luxembourg
N. Arber - Tel Aviv Medical Center, Tel-Aviv University, Tel Aviv, Israel
J.D. Berlin - Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, USA
M.W. Büchler - University of Heidelberg, Heidelberg, Germany
A. Cervantes - Institute of Health Research INCLIVIA, University of Valencia, Valencia, Spain
F. Ciardiello - Second University of Naples, Naples, Italy
M. Ducreux - Institut Gustave Roussy, Villejuif
J.Y. Douillard - Centre René Gauducheau, Nantes, France
A. Grothey - Mayo Clinic
D. Haller - Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
K. Haustermans - Radiation Oncology, University Hospitals Leuven, Leuven
V. Heinemann - Ludwig-Maximilian-University of Munich, Munich, Germany
M. Hidalgo - Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
R. Labianca - Giovanni XXIII Hospital, Bergamo, Italy
J. Li - Fudan University Cancer Center, Shanghai, China
J.L. Marshall - Georgetown University, Washington, USA
B. Nordlinger - Ambroise Paré Hospital, Boulogne, France
E.M. O'Reilly - Memorial Sloan-Kettering Cancer Center, New York, USA
A. Roth - Geneva University Hospital, Geneva, Switzerland
P. Rougier - Hôpital Européen Georges Pompidou, Paris, France
D. Ryan - Harvard Medical School, Massachusetts General Hospital, Boston, USA
W. Schmiegel - University Hospital Bochum, Bochum
T. Seufferlein - Department of Internal Medicine I, University of Ulm, Ulm
H.J. Schmoll - Martin Luther University, Halle, Germany
A. Sobrero - San Martino Hospital, Genoa, Italy
J. Tabernero - Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
M. Tempero - Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, USA
J.L. Van Laethem - Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium
M. Ychou - CRLC Val d'Aurelle, Montpellier, France
J. Zalcberg - Division of Cancer Medicine, Peter MacCallum Cancer Center, Melbourne, Australia
Détails de publication: Annals of oncology, Vol.24, pp.iv5-iv10
Éditeur: Elsevier Ltd
Identifiants: 99141273209311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM
Langue: English
Type de ressource: Journal article